Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA.
Bioorg Med Chem Lett. 2011 Apr 1;21(7):2040-3. doi: 10.1016/j.bmcl.2011.02.011. Epub 2011 Feb 25.
Bombesin receptor subtype-3 (BRS-3) is an orphan G-protein coupled receptor belonging to the subfamily of bombesin-like receptors. BRS-3 is implicated in the development of obesity and diabetes. We report here small-molecule agonists that are based on a 4-(alkylamino)pyridine-3-sulfonamide core. We describe the discovery of 2a, which has mid-nanomolar potency, selectivity for human BRS-3 versus the other bombesin-like receptors, and good bioavailability.
蛙皮素受体亚型-3(BRS-3)是一种孤儿 G 蛋白偶联受体,属于蛙皮素样受体亚家族。BRS-3 与肥胖和糖尿病的发展有关。我们在此报告了基于 4-(烷基氨基)吡啶-3-磺酰胺核心的小分子激动剂。我们描述了 2a 的发现,它具有中纳摩尔效力,对人 BRS-3 相对于其他蛙皮素样受体的选择性,以及良好的生物利用度。